Session: Access, Utilization, and Costs of Psychotropic Medications


Back to Annual Meeting Page		American Public Health Association 133rd Annual Meeting & Exposition December 10-14, 2005 Philadelphia, PA

3208.0: Monday, December 12, 2005: 12:30 PM-2:00 PM

Oral

Access, Utilization, and Costs of Psychotropic Medications

Results from a variety of studies related to access, utilization, and costs of psychotropic medications will be presented by leading researchers in the field.

Learning Objectives: At the conclusion of the session, the participant (learner) in this session will be able to identify current, leading issues related to access, utilization, and costs of psychotropic medications.

Moderator(s):

Susan DosReis, PhD

12:30 PM

Psychotropic polypharmacy and racial disparities in patients with bipolar disorder

David Garver, MD, Arthur Lazarus, MD, Kitty Rajagopalan, PhD, Laura M. Katz, MPH, Lee S. Stern, MS, Margarita Dolgitser, John J. Doyle, DrPH

12:45 PM

Private health plans’ management of psychotropic drugs

Dominic Hodgkin, PhD, Constance M. Horgan, ScD, Deborah Garnick, ScD, Elizabeth L. Merrick, PhD, MSW, Joanna Volpe-Vartanian, MS, LICSW

1:00 PM

Prescription Drug Expenditure and Dual Eligibility among non-Elderly Medicaid Beneficiaries Diagnosed with Severe Mental Illness

Wenhui Wei, MA, MS, Yujing Shen, PhD, Patricia A. Findley, DrPH, MSW, James T. Walkup, PhD, Stephen Crystal, PhD

1:15 PM

Racial and SES Differences in Parental Understanding of Stimulant Medication

Susan DosReis, PhD, Arlene Butz, CRNP, ScD, Paul Lipkin, MD, Julia Anixt, MD, Courtney L. Weiner, Robin Chernoff, MD

1:30 PM

Medication decision making by persons with serious mental illness

Irma H. Mahone, MSN, PhD (c)

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by:

Mental Health

Endorsed by:

Gerontological Health

CE Credits:

CME, Health Education (CHES), Nursing

The 133rd Annual Meeting & Exposition (December 10-14, 2005) of APHA